NCT03049449 2023-01-18T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing LymphomasNational Institutes of Health Clinical Center (CC)Phase 1 Completed26 enrolled 19 charts